BGNE
StockBGNE
Key Stats
Market Cap
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Volume
N/A
Avg Volume
N/A
Performance
1M
N/A
3M
N/A
6M
N/A
YTD
N/A
1Y
N/A
3Y
-20.15%
5Y
-43.23%
Price Chart
ETF Exposure
BGNE is held by 16 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MSGR | Direxion mRNA ETF | 7.51% |
| IVSG | Invesco Select Growth ETF | 4.01% |
| ERSX | ERShares NextGen Entrepreneurs ETF | 3.34% |
| CNCR | Loncar Cancer Immunotherapy ETF | 3.19% |
| ENTR | L&G Energy Transition Commodities UCITS ETF | 2.07% |
| CHNA | Loncar China BioPharma ETF | 1.89% |
| BBP | Virtus Biotech ETF | 1.46% |
| BAD | B.A.D. ETF | 1.34% |
| LNGR | Global X Aging Population ETF | 1.30% |
| ADRE | Invesco BLDRS Emerging Markets 50 ADR Index Fund | 1.14% |
| FNI | First Trust Chindia ETF | 0.91% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.73% |
| DMRE | DeltaShares S&P EM 100 & Managed Risk ETF | 0.40% |
| AVSE | Avantis Responsible Emerging Markets Equity ETF | 0.03% |
| LVHB | Innovator Laddered Allocation Power Buffer ETF | 0.02% |
| AVEM | Avantis Emerging Markets Equity ETF | 0.02% |
About BGNE ETF Exposure
BGNE (BGNE) is held by 16 exchange-traded funds, making it one of the stocks with significant ETF exposure. Investors can gain exposure to BGNE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BGNE, sorted by portfolio weight.